SelectScience
Join Free
Accelerating Science
NewsDrug Discovery & Development

The AI Driven Drug Development Summit lands in Europe in April 2023

Kisaco Research

Uniting executives from across the pharmaceutical industry to provide insights into accelerated drug discovery and clinical research through artificial-intelligence.

8 Mar 2023
Jemima Arnold
Editorial Assistant

Industry news

On April 26 and 27 2023, the AI-Driven Drug Development Summit: EUROPE is the next exclusive event in the series joining the previous inaugural AI-Driven Drug Discovery and AI-Enhanced Clinical Trials USA Summits.

The event will be attended by senior executives of the pharmaceutical industry who provide expertise and collaborative opportunities across the landscape of developmental pipelines.

Key themes of the summit will include:

Drug Discovery Focus:

  • Predictive modeling of ADME & pharmacokinetic parameters
  • Applying deep learning to generative small-molecule discovery
  • Maximizing the impact of big data
  • Predicting cell line viability in precision medicine

Clinical Research Focus:

  • Advancing clinical trial studies through AI
  • Federated machine learning integration in clinical research
  • Geometric deep learning on structured data domains
  • Guiding clinical research with optimum RWE

Download the official agenda to discover more about the exclusive industry meeting point, speakers attending the event will include:

  • Nick Brown: Executive Director of Imaging and Analytics – AstraZeneca
  • Richard Lewis: Director of Data Science – Novartis
  • Christopher Langmead: Director of Digital Biologics Discovery – Amgen
  • Helena Andres-Terre, Associate Director – UCB
  • Claus Andersen, Project Director, Data Orchestration, NovoNordisk

Find out more information about the summit and download the agenda, today.

Links

Kisaco ResearchCompany website

Tags

Combinatorial ChemistryCombinatorial chemistry, also known as combichem, is a technique used in drug discovery to create libraries of structurally related compounds. A library is generated by synthesis with a chemical reactor system or by computer-based modeling of compound combinations. When undertaking combinatorial chemistry consider reagents, buffers, resins and standards.Clinical TrialsClinical Trials, an essential part of drug discovery process, assess the safety and effectiveness of a new medication or device in the pharmaceutical industry. Clinical Trials are a phased process (Phase 0, Phase I, Phase II, Phase III and Phase IV) which begins after initial preclinical testing.Discovery SoftwareComputational techniques used in both the chemistry and biology aspects of drug discovery, for data acquisition, processing and storage. Software is used for analysis of pathways, target identification, genomics, proteomics, modelling, lead identification, compound analysis and drug modelling among many others. Drug DiscoveryDrug discovery is the process of identifying potential new medications, involving stages such as target identification, compound screening, and preclinical development. It relies on cutting-edge technologies like high-throughput screening, artificial intelligence, and molecular modeling to accelerate the identification of drug candidates. Drug discovery plays a pivotal role in developing new therapies for diseases ranging from cancer to rare genetic disorders. Browse our peer-reviewed product directory to find the latest drug discovery technologies, compare options, check customer feedback, and get pricing directly from manufacturers.Drug DevelopmentDrug development refers to the process of bringing a new drug to market.

Related articles